News
RFK Jr. cancels $500M US in funding for vaccine development, targeting mRNA
The U.S. Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu, specifically targeting vaccines that use mRNA technology.
The decision will impact 22 projects speerheaded by major pharmaceutical companies for vaccines against bird flu and other ...
Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.
During the Covid-19 pandemic, vaccine stocks shot up on the promise that they could end the lockdowns. Many vaccines were developed, but few were approved. Since the end of 2021, even the approved ...
Novavax raised its full-year adjusted revenue forecast on Wednesday, betting on the strength of vaccine supply partnerships, including with Serum Institute of India and Japan's Takeda , sending its ...
Vaccine Stock #2: Moderna Moderna, Inc. (MRNA), founded in 2010 and headquartered in Cambridge, Massachusetts, is a biotech pioneer with a $14.2 billion market cap.
Surely, it’s not just a coincidence that Novavax stock catapulted higher in mid-May, during the resurgence of meme-stock mania. This wasn’t just a relief rally for COVID-19 vaccine stocks; it ...
Asia Global stocks mixed amid vaccine, stimulus optimism BEIJING - Global stock markets were mixed Monday amid optimism about government stimulus and the rollout of coronavirus vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback